476 results match your criteria: "Centre d'Immunologie et des Maladies Infectieuses CIMI[Affiliation]"
Elife
August 2024
Centre d'Immunologie et des Maladies Infectieuses (CIMI-PARIS), INSERM, CNRS, Sorbonne Université, Paris, France.
CD4CD25Foxp3 regulatory T cells (Treg) have been implicated in pain modulation in various inflammatory conditions. However, whether Treg cells hamper pain at steady state and by which mechanism is still unclear. From a meta-analysis of the transcriptomes of murine Treg and conventional T cells (Tconv), we observe that the proenkephalin gene (), encoding the precursor of analgesic opioid peptides, ranks among the top 25 genes most enriched in Treg cells.
View Article and Find Full Text PDFTransplantation
July 2024
Sorbonne Université, Inserm U1135, CNRS EMR 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.
Background: Uterus transplantation (UTx) is an emerging therapy for women with uterine infertility. However, critical questions remain with this procedure including the mechanisms involved in graft rejection.
Methods: In this study, we analyzed the immune profile of ectocervical biopsies from 5 patients after UTx before and during their first episode of rejection using RNA sequencing, quantitative polymerase chain reaction, and imaging mass cytometry.
Med Sci (Paris)
July 2024
Sorbonne Université, Inserm U1135, CNRS ERL8285, Centre d'immunologie et des maladies infectieuses (CIMI-Paris), Hôpital Pitié-Salpêtrière, Paris, France.
Joint Bone Spine
December 2024
Sorbonne Université, Inserm, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France; Sorbonne Université, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte d'Ile-de-France, Centre et Martinique, Service de Médecine Interne 2, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, Institut E3M, Paris, France. Electronic address:
Objective: Previous studies have provided evidence that the discontinuation of hydroxychloroquine (HCQ), and chloroquine (CQ), in patients with systemic lupus erythematosus (SLE) is associated with an increased risk of disease flares, with limited information on the level of disease activity at the time of HCQ/CQ discontinuation. Here we aimed to describe the risk of SLE flare after withdrawal of HCQ or CQ in patients with SLE in remission.
Methods: Case-control study (1:2) comparing the evolution of patients with SLE after HCQ/CQ withdrawal for antimalarial retinopathy (cases) with patients with SLE matched for sex, antimalarial treatment duration and age at SLE diagnosis, whose antimalarial treatment was continued throughout the entire follow-up period (controls).
Nat Cell Biol
July 2024
Institut Curie, PSL Research University, CNRS, UMR144, 26 rue d'Ulm, 75248, Paris Cedex 05, France.
Extracellular vesicles such as exosomes are now recognized as key players in intercellular communication. Their role is influenced by the specific repertoires of proteins and lipids, which are enriched when they are generated as intraluminal vesicles (ILVs) in multivesicular endosomes. Here we report that a key component of small extracellular vesicles, the tetraspanin CD63, sorts cholesterol to ILVs, generating a pool that can be mobilized by the NPC1/2 complex, and exported via exosomes to recipient cells.
View Article and Find Full Text PDFMicrob Biotechnol
June 2024
U1135, Centre d'Immunologie et Des Maladies Infectieuses (Cimi-Paris), Sorbonne Université, Paris, France.
Clostridioides difficile (CD) infections are defined by toxins A (TcdA) and B (TcdB) along with the binary toxin (CDT). The emergence of the 'hypervirulent' (Hv) strain PR 027, along with PR 176 and 181, two decades ago, reshaped CD infection epidemiology in Europe. This study assessed MALDI-TOF mass spectrometry (MALDI-TOF MS) combined with machine learning (ML) and Deep Learning (DL) to identify toxigenic strains (producing TcdA, TcdB with or without CDT) and Hv strains.
View Article and Find Full Text PDFRev Prat
April 2024
Service de dermatologie et allergologie, hôpital Tenon, Paris, France. Sorbonne université, UPMC université Paris-VI, unité mixte de recherche santé (UMR S) CR7, Centre d'immunologie et des maladies infectieuses (CIMI), Paris, Institut national de santé et de recherche médicale (Inserm) U1135, CIMI, Paris, France.
Ann Rheum Dis
September 2024
Médecine Interne, CEREMAIA, Sorbonne Université, Hospital Tenon, Paris, France
Objectives: Vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic (VEXAS) syndrome is an adult-onset autoinflammatory disease associated with somatic ubiquitin-like modifier-activating enzyme 1 (UBA1) mutations. We aimed to evaluate the efficacy and safety of targeted therapies.
Methods: Multicentre retrospective study including patients with genetically proven VEXAS syndrome who had received at least one targeted therapy.
Funct Integr Genomics
May 2024
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France.
COVID-19 is associated with heterogeneous outcome. Early identification of a severe progression of the disease is essential to properly manage the patients and improve their outcome. Biomarkers reflecting an increased inflammatory response, as well as individual features including advanced age, male gender, and pre-existing comorbidities, are risk factors of severe COVID-19.
View Article and Find Full Text PDFInt J Parasitol
August 2024
Department of Molecular Parasitology, Institute of Biology, Humboldt University, Berlin, Germany; Department of Biological Sciences, Macquarie University, Sydney, Australia; Museum für Naturkunde, Leibniz-Institute for Evolution and Biodiversity Science, Berlin, Germany; Department of Biology, Muni University, Arua, Uganda. Electronic address:
Malaria remains the most important arthropod-borne infectious disease globally. The causative agent, Plasmodium, is a unicellular eukaryote that develops inside red blood cells. Identifying new Plasmodium parasite species that infect mammalian hosts can shed light on the complex evolution and diversity of malaria parasites.
View Article and Find Full Text PDFEur J Cardiothorac Surg
May 2024
AP-HP, Unité de Recherche Clinique, Hôpitaux Saint Louis-Lariboisière-Fernand Widal, Université Paris Cité, Paris, France.
JAMA Netw Open
April 2024
INSERM, U1111, CNRS, UMR 5308, CIRI-GIMAP, Université Claude Bernard Lyon 1, Université Jean Monnet, Immunology and Immunomonitoring Laboratory, iBiothera, CIC 1408, Saint-Étienne, France.
Importance: There is still considerable controversy in the literature regarding the capacity of intramuscular messenger RNA (mRNA) vaccination to induce a mucosal immune response.
Objective: To compare serum and salivary IgG and IgA levels among mRNA-vaccinated individuals with or without previous SARS-CoV-2 infection.
Design, Setting, And Participants: In this cohort study, SARS-CoV-2-naive participants and those with previous infection were consecutively included in the CoviCompare P and CoviCompare M mRNA vaccination trials and followed up to day 180 after vaccination with either the BNT162b2 (Pfizer-BioNTech) vaccine or the mRNA-1273 (Moderna) vaccine at the beginning of the COVID-19 vaccination campaign (from February 19 to June 8, 2021) in France.
Curr Rheumatol Rep
July 2024
Hôpital La Pitié-Salpêtrière, Service de Médecine Intensive-Réanimation, Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Purpose Of The Review: Antiphospholipid syndrome (APS) is a rare systemic autoimmune disorder that can escalate into a 'thrombotic storm' called the catastrophic antiphospholipid syndrome (CAPS), frequently requiring ICU admission for multiple organ failure. This review aims to offer insight and recent evidence on critically-ill APS patients.
Recent Findings: The CAPS classification criteria define this condition as the involvement of at least three organs/systems/tissues within less than a week, caused by small vessel thrombosis, in patients with elevated antiphospholipid antibodies levels.
Heliyon
April 2024
Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants-malades, Assistance publique-Hôpitaux de Paris, 149 rue de Sèvres, 75743, Paris, France.
Immune reconstitution inflammatory syndrome (IRIS) has been reported in immunocompromised patients with disseminated . Management relies on high-dose corticosteroids. We describe two cases of late-onset corticosteroid-refractory IRIS related to disseminated infection in a HIV-positive patient and a renal transplant patient who had a favorable outcome with a monoclonal TNF-α blocker.
View Article and Find Full Text PDFEClinicalMedicine
April 2024
Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance Publique - Hôpitaux de Paris (AP-HP), Clinical Investigation Center (CIC-1901), Regional Pharmacovigilance Centre, Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France.
Rev Prat
March 2024
AP-HP. Sorbonne Université, Centre national de référence des mycobactéries et de la résistance des mycobactéries aux antituberculeux, Paris, France. Sorbonne université, Inserm U1135, Centre d'immunologie et des maladies infectieuses (Cimi), Paris, France.
ADVANCES IN ANTIBIOTIC THERAPY FOR TUBERCULOSIS. Treatment of tuberculosis is experiencing significant advancements. For the first time, a therapeutic regimen based on rifapentine and moxifloxacin allows for a reduction of treatment duration of drug-susceptible tuberculosis from 6 to 4 months.
View Article and Find Full Text PDFAntimicrob Agents Chemother
May 2024
Unit of Mycobacteriology, Institute of Tropical Medicine, Antwerp, Belgium.
J Exp Med
May 2024
CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308 , ENS de Lyon, Lyon, France.
Am J Hematol
June 2024
Internal medicine Dpt, Hôpital Saint-Louis, APHP, Université Paris-Cité, INSERM U976-HIPI, Centre de Référence des Maladies Auto-Immunes Systémiques Rares d'Ile-de-France, Filière FAI2R, Paris, France.
Int J Infect Dis
May 2024
Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié, Salpêtrière, Service de Parasitologie-Mycologie, Paris, France.
Front Immunol
March 2024
Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Med Sci (Paris)
February 2024
GreenLab, Centre d'immunologie et des maladies infectieuses (CIMI-Paris), Sorbonne-université, HôpitalPitié-Salpêtrière, Inserm U1135, CNRS ERL8255, Paris, France.
Med Sci (Paris)
February 2024
Laboratoire « Microenvironnement immunitaire et immunothérapie », Centre d'immunologie et des maladies infectieuses (CIMI), Inserm U1135, Faculté de Santé, Sorbonne université, Paris, France.
Semin Arthritis Rheum
June 2024
Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP), Groupe Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France. Electronic address:
Background: Long-term hydroxychloroquine (HCQ) or chloroquine (CQ) intake causes retinal toxicity in 0.3-8 % of patients with rheumatic diseases. Numerous risk factors have been described, eg, daily dose by weight, treatment duration, chronic kidney disease, concurrent tamoxifen therapy and pre-existing retinal or macular disease.
View Article and Find Full Text PDFClin Exp Rheumatol
July 2024
Assistance Publique - Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, Centre National de Référence pour le Lupus, le Syndrome des Anticorps Anti-phospholipides et Autres Maladies Auto-immunes Rares, Service de Médecine Interne 2, Institut E3M; and Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.